Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|June 23, 2016

Thermo Fisher and NIBRT Link Up for Characterization Project

Thermo will provide access to its instruments to NIBRT so that the Dublin-based group can generate helpful characterization data.

The National Institute for Bioprocessing Research and Training (NBIRT) will use Thermo Fisher Scientific’s columns, consumables, liquid chromatography systems, and mass spectrometers for research on biopharmaceutical characterization, Thermo announced on June 23, 2016. NIBRT will develop analytical workflows and contribute insights to improve the technology, simplify analysis, and generate informative characterization data on complex biopharmaceuticals.

NIBRT’s findings and analytical methods will be uploaded to the Thermo Scientific AppLab library so that scientists can download these workflows directly to their instruments. The goal of the cloud-based app is to simplify analysis for those using Thermo machines and provide these scientists with characterization data to use as a training tool to understand complex molecules more thoroughly.


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.